Navigation Links
Newly discovered kinase regulates cytoskeleton, and perhaps holds key to how cancer cells spread
Date:5/31/2010

Scientists at the University of California, San Diego have identified a previously unknown kinase that regulates cell proliferation, shape and migration, and may play a major role in the progression or metastasis of cancer cells.

The research will be published in the May 31 online Early Edition of the Proceedings of the National Academy of Sciences.

Richard L. Klemke, PhD, professor of pathology at the UCSD School of Medicine and the Moores Cancer Center, and colleagues say the new kinase or enzyme regulates the cytoskeleton the internal framework of tiny filaments and microtubules in cells that gives them shape, coherence and the ability to move.

"This molecule may be an important new target for future anticancer therapies and a clinical biomarker that predicts whether a cancer is likely to spread," said Klemke.

Proper regulation of the cytoskeleton is important to many fundamental cellular functions, including axon/dendrite formation, migration, differentiation and proliferation. Conversely, deregulation of the cytoskeleton can contribute to a variety of human diseases, including cancer metastasis or the spread of tumors to other parts of the body.

The new kinase called pseudopodium-enriched atypical kinase one or PEAK1 plays a central role in the formation of cellular pseudopodia. Greek for "false foot," a pseudopodium is a highly specialized structure that protrudes from the surface of migrating cells. It attaches the leading, extending membrane of the cell to its underlying substrate, and then helps pull the cell forward. By endlessly repeating this process, a cell is able to move in a productive manner.

"Cancer cells capitalize on their innate ability to move in this fashion when they metastasize," said Jonathan A. Kelber, PhD, leading author on the paper and postdoctoral fellow in Klemke's lab. "Cancer cells detach from the primary tumor, invade the extracellular milieu and then enter the vascular system from which they can spread and seed new tumors in distant tissues."

Discovering PEAK1 provides researchers with a new player to study and investigate, one that may have significant influence in the biology of cells, particularly cancer cells. Evidence from mouse studies suggests PEAK1 is an important player during tumor growth, and Klemke's team has further demonstrated that PEAK1 levels are increased in primary and metastatic samples from human colon cancer patients. Whether PEAK1 is capable of transforming non-tumor cells into cancer cells remains to be determined.

"One exciting fact is that PEAK1 has kinase activity, which suggests you can design a small molecule drug that would specifically inhibit its activity," said Kelber. "But that work lies in the future. First, we need to fully identify the role of its kinase domain in tumor progression."


'/>"/>

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Source:Eurekalert

Related biology news :

1. Newly created cancer stem cells could aid breast cancer research
2. Newly-identified exercise gene could help with depression
3. Newly defined signaling pathway could mean better biofuel sources
4. Newly identified role for power plants in human cells could lead to targeted therapies
5. Death, division or cancer? Newly discovered checkpoint process holds the line in cell division
6. Newly described dragon protein could be key to bird flu cure
7. Leatherback turtles newly discovered migration route may be roadmap to salvation
8. Newly discovered monkey is threatened with extinction
9. Newly discovered molecular switch helps decide cell type in early embryo development
10. Genes newly explained effect on height may change tumor disorder treatment
11. Newly-discovered mechanism can explain the Beckwith-Wiedemann syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... First quarter 2016:   , Revenues amounted to ... of 2015 The gross margin was 49% (27) ... operating margin was 40% (-13) Earnings per share rose ... was SEK 249.9 M (21.2) , Outlook   ... The operating margin for 2016 is estimated to exceed ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
Breaking Biology News(10 mins):
(Date:4/27/2016)... MIAMI (PRWEB) , ... April 27, 2016 , ... ... a mutual endorsement of an Asia-Pacific Symposium as other research and development initiatives for ... of Santiago officials and top Global Stem Cells Group executives began meeting to establish ...
(Date:4/26/2016)... CAMBRIDGE, Mass. (PRWEB) , ... April 26, 2016 , ... ... Herr has been selected as one of three finalists for the European Inventor ... the EPO’s annual innovation prize will be announced at a ceremony in Lisbon on ...
(Date:4/26/2016)... ... April 26, 2016 , ... Seattle based non-profit, ... grant from 1Plus12 Corporation. The grant will be used to further the scientific ... the organization's website http://www.ivsci.org , In accounting the grant to the ...
(Date:4/26/2016)... April 26, 2016 Celsion Corporation (NASDAQ: ... today announced that the first patient in ... its ongoing global Phase III OPTIMA Study evaluating ... in combination with radiofrequency ablation standardized to 45 ... diagnosed patients with primary liver cancer, also known ...
Breaking Biology Technology: